Startup | November 13, 2021
DawaDost rolls out diabetes medicine at Re 1 per day
The start-up has announced the scheme to mark World Diabetes Day
The start-up has announced the scheme to mark World Diabetes Day
The new manufacturing facility will be built at a subsidiary of Adcock Ingram and will commence operation in March 23
The injunction order has been passed against Natco Pharma, Torrent Pharmaceuticals, Eris Lifesciences and Windlas Biotech
A total of 12 generic medicines have been included in the list
Key takeaways of recent quarter & conference call highlights
The company claims that its Empagliflozin tablets are the most affordable in India
It is the first presbyopia-correcting lens implant for cataract surgery
According to industry sales data, the 10mg strength of Afinitor generated annual sales of US $ 392 million during the twelve months ending July 2021
In terms of volume, the company commands a market share 25 per cent globally for Gliclazide, as per the IQVIA report
Zydus' Apremilast tablets are indicated for the treatment of adult patients with moderate to severe plaque psoriasis who are candidates for phototherapy or systemic therapy
Subscribe To Our Newsletter & Stay Updated
